Moderator Emeritus Addax Posted May 13, 2023 Moderator Emeritus Share Posted May 13, 2023 Biomedicine and Psychopharmacology. 2023. https://doi.org/10.1016/j.biopha.2022.114166 Link to PDF: HERE Abstract Background Although Post-SSRI Sexual Dysfunction (PSSD) has finally been recognized by the European Medicines Agency as a medical condition that can outlast discontinuation of SSRIand SNRI antidepressants, this condition is still largely unknown by patients, doctors, and researchers, and hence, poorly understood, underdiagnosed, and undertreated. Objective Becoming familiar with the symptomatology of PSSD and understanding the underlying mechanisms and treatment options. Method We applied a design thinking approach to innovation to 1) provide insights into the medical condition as well as the personal needs and pains of a targeted patient; and 2) generate ideas for new solutions from the perspective of this particular patient. These insights and ideas informed a literature search on the potential pathophysiological mechanisms that could underlie the patient’s symptoms. Results The 55-year-old male patient developed symptoms of low libido, delayed ejaculation, erectile dysfunction, ‘brain zaps’, overactive bladder and urinary inconsistency after discontinuation of the SNRI venlafaxine. In many of these symptoms a dysregulation in serotonergic activity has been implicated, with an important role of 5-HT1A receptor downregulation and possible downstream effects on neurosteroid and oxytocin systems. Conclusions The clinical presentation and development of symptoms are suggestive of PSSD but need further clinical elaboration. Further knowledge of post-treatment changes in serotonergic – and possibly noradrenergic – mechanisms is required to improve our understanding of the clinical complaints and to inform appropriate treatment regimes. 1988-2012: Prozac @ 60mg (with a few stops and starts) Fall 2012: Returned to 40mg after discontinuing and horrid withdrawal Fall 2013: 40mg Fluoxetine, added 150mg Wellbutrin to treat fatigue Winter 2014: Attempting to taper both (too fast) April 2014: 9mg Fluoxetine + 37.5 Wellbutrin Summer 2014: 8 mg Fluoxetine + 0 Wellbutrin (way too fast a drop) Late summer/Early Fall 2014: Debilitating Withdrawal symptoms Fall 2014 - Wellbutrin successfully kicked to the curb but… Oct- Dec 2014: Panicked reinstatement of Fluoxetine ->30mg - held for 5yrs Jan 2021: taper to 20mg Fluoxetine then tapering by 1mg every 2-3 months Fall 2022 - held at 10mg->December 2022: 9mg->Feb 2023: 8mg ->March 2023: brassmonkey slide begins: 7.8mg -> 7.6 -> 7.4->2 week hold (April)->7.2->7mg->6.8->2 week hold->6.6-> 1-month hold ->(June)-6.5->4-week hold-> (July)-6.4 (discontinued brassmonkey slide and slowed taper)-> (Aug)-6.2->(Sept)-6.0->(Oct)-5.9->(Nov)-5.8->(Dec)-5.7->wave!->(Jan)-5.8->(Feb)-6mg and holding. My 2014 withdrawal experience: https://rxisk.org/antidepressant-withdrawal-a-prozac-story/ Link to comment Share on other sites More sharing options...
Recommended Posts